Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Total Stockholders Equity : ¥4,101 Mil (As of Mar. 2025)

View and export this data going back to 1999. Start your Free Trial

What is Tibet Rhodiola Pharmaceutical Holding Co Total Stockholders Equity?

Tibet Rhodiola Pharmaceutical Holding Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥4,101 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Tibet Rhodiola Pharmaceutical Holding Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥12.79. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Tibet Rhodiola Pharmaceutical Holding Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.13.

Tibet Rhodiola Pharmaceutical Holding Co Total Stockholders Equity Historical Data

The historical data trend for Tibet Rhodiola Pharmaceutical Holding Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Rhodiola Pharmaceutical Holding Co Total Stockholders Equity Chart

Tibet Rhodiola Pharmaceutical Holding Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

2,576.09

2,630.36

3,011.77

3,344.59

3,917.82

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															3,659.32	3,791.72	3,629.96	3,917.82	4,101.03

Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Tibet Rhodiola Pharmaceutical Holding Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4101.032	-	0)	/	320.572
	=	12.79

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Tibet Rhodiola Pharmaceutical Holding Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(517.092	+	0.128)	/	4101.032
	=	0.13

Tibet Rhodiola Pharmaceutical Holding Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Tibet Rhodiola Pharmaceutical Holding Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Rhodiola Pharmaceutical Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 93, Beijing Middle Road, Tibet Autonomous Region, Lhasa, CHN, 610023

Website

http://www.xzyy.cn

Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.

Executives

Wang Bao Ming	senior management
Peng Hui	Director
Cao Shu Zhen	senior management
Si Qin	Director
Ren Bei Chen	Supervisors
Liu De Gong	Supervisors
Gao Zi Li	senior management
Zhou Ming De	senior management
Chen Li Ye	senior management
Lin Ben	Director
Chen Da Bin	Director

Tibet Rhodiola Pharmaceutical Holding Co Headlines

No Headlines